TY - JOUR
T1 - Effects of Sedation on Auditory Brainstem Response in Rett Syndrome
AU - Pillion, Joseph P.
AU - Bibat, Genila
AU - Naidu, Sakkubai
N1 - Funding Information:
Support is acknowledged from U.S. National Institutes of Health grant HD24448 (Pathogenesis of Rett Syndrome), U.S. Food and Drug Administration grant FD-R-002408-04 , and Johns Hopkins Pediatric Clinical Research Center Grant RR-00052 to S.N.
PY - 2010/5
Y1 - 2010/5
N2 - Prolongation of the I-V interpeak latency intervals have been reported in Rett syndrome and other neurodevelopmental disorders. It has been suggested that the use of sedation may account for differences in the interpeak latency intervals when comparisons are made across diagnostic groups if sedated control groups are not used for the basis of comparison. This study examined the effects of sedation on auditory brainstem response interpeak latency intervals (i.e., I-III, III-V, and I-V) in two groups: (1) a group with Rett syndrome who were positive for mutations in the MECP2 gene and (2) a group negative for mutations in the MECP2 gene but who were severely to profoundly delayed with other causes of mental retardation. To further assess the effects of sedation, a third group of sedated and nonsedated female participants, taken from an in-house normative auditory brainstem response database was also included. An analysis of variance indicated (1) longer I-V interpeak latency intervals in the sedated participants with Rett syndrome; (2) longer III-V interpeak latency intervals in the mutation-positive participants as compared to non-Rett syndrome, mutation-negative participants; and (3) no significant effects of sedation on the I-III, III-V, or I-V interpeak latency intervals among the normative group participants, according to t tests. The findings suggest a possible biological basis for the discrepancy in the literature on auditory brain stem responses in Rett syndrome, and warrant cautious interpretation of auditory brainstem responses findings in sedated subjects with Rett syndrome, as well as in those with mental retardation and seizures.
AB - Prolongation of the I-V interpeak latency intervals have been reported in Rett syndrome and other neurodevelopmental disorders. It has been suggested that the use of sedation may account for differences in the interpeak latency intervals when comparisons are made across diagnostic groups if sedated control groups are not used for the basis of comparison. This study examined the effects of sedation on auditory brainstem response interpeak latency intervals (i.e., I-III, III-V, and I-V) in two groups: (1) a group with Rett syndrome who were positive for mutations in the MECP2 gene and (2) a group negative for mutations in the MECP2 gene but who were severely to profoundly delayed with other causes of mental retardation. To further assess the effects of sedation, a third group of sedated and nonsedated female participants, taken from an in-house normative auditory brainstem response database was also included. An analysis of variance indicated (1) longer I-V interpeak latency intervals in the sedated participants with Rett syndrome; (2) longer III-V interpeak latency intervals in the mutation-positive participants as compared to non-Rett syndrome, mutation-negative participants; and (3) no significant effects of sedation on the I-III, III-V, or I-V interpeak latency intervals among the normative group participants, according to t tests. The findings suggest a possible biological basis for the discrepancy in the literature on auditory brain stem responses in Rett syndrome, and warrant cautious interpretation of auditory brainstem responses findings in sedated subjects with Rett syndrome, as well as in those with mental retardation and seizures.
UR - http://www.scopus.com/inward/record.url?scp=77950606174&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=77950606174&partnerID=8YFLogxK
U2 - 10.1016/j.pediatrneurol.2010.01.003
DO - 10.1016/j.pediatrneurol.2010.01.003
M3 - Article
C2 - 20399386
AN - SCOPUS:77950606174
SN - 0887-8994
VL - 42
SP - 331
EP - 334
JO - Pediatric Neurology
JF - Pediatric Neurology
IS - 5
ER -